Skip to content
DataLookout
Menu

BionanoNCT07133789

The Contribution of Optical Mapping to the Characterization of Chromosomal Rearrangements in Patients With Neurodevelopmental Disorders

StatusCompleted
PhaseNot specified
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 4 words
    • Trial completed
    • Study description revised
    • Site details revised
  2. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Precise characterization of chromosomal segments involved in duplications or complex chromosomal rearrangements identified in ACPA
Timeframe: 24 months

Arms and interventions

Other: blood sampling of all patients and their parents

Sites

1 site in 1 country

  • Robert Debré HospitalParis, France